top of page
website background 1.png

Turning the tides against lung cancer 

"Lung cancer is the leading cause of cancer-related deaths worldwide"
- International Agency for Research on Cancer, 2023
What we do?

At Terasom, we harness and bioengineer exosomes—naturally occurring extracellular vesicles secreted by all human cells—to confront lung cancer across its entire clinical spectrum. Whether a patient is navigating stage IV disease, struggling with post-surgery symptoms, or simply in the high-risk category, our exosome-based approach is designed to intervene, support, and prevent lung cancer, to ensure everyone can breathe easy.

How we do this?

With the power of exosomes, we have created:

  • A novel platform for rapid early-stage lung cancer diagnostics

  • An immunotherapy vaccine for solid tumours

  • An exosome-based drug that can induce the regeneration of elastin

bottom of page